Real-time enrollment status for this lung cancer clinical trial
Current Status
Recruiting
Checked: August 31, 2026 at 7:04 PM UTC
| NCT Number | NCT05920356 |
| Recruiting Status | Recruiting |
| Condition | Lung Cancer |
| Phase | PHASE3 |
| Target Enrollment | 750 participants |
| Active Locations | 25 sites in the US |
| Sponsor | Amgen |
| Last Updated on CT.gov | August 27, 2026 (4 days ago) |
As of August 31, 2026: Clinical trial NCT05920356 is currently recruiting participants. This phase3 study for lung cancer is actively seeking new participants at 25 locations across the United States. The study is sponsored by Amgen. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05920356 is actively recruiting participants as of August 31, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 25 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05920356 was last updated 4 days ago (August 27, 2026). HelloStudys verifies this status automatically.